Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation

BACKGROUND: Oral anticoagulation (OAC) reduces the risk of thromboembolic events in patients with atrial fibrillation (AF); however, thromboembolism (TE) still can occur despite OAC. Factors associated with residual risk for stroke, systemic embolism, or transient ischemic attack events despite OAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlisle, Matthew A., Shrader, Peter, Fudim, Marat, Pieper, Karen S., Blanco, Rosalia G., Fonarow, Gregg C., Naccarelli, Gerald V., Gersh, Bernard J., Reiffel, James A., Kowey, Peter R., Steinberg, Benjamin A., Freeman, James V., Ezekowitz, Michael D., Singer, Daniel E., Allen, Larry A., Chan, Paul S., Pokorney, Sean D., Peterson, Eric D., Piccini, Jonathan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795305/
https://www.ncbi.nlm.nih.gov/pubmed/36589908
http://dx.doi.org/10.1016/j.hroo.2022.09.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795305/
https://www.ncbi.nlm.nih.gov/pubmed/36589908
http://dx.doi.org/10.1016/j.hroo.2022.09.018

Ejemplares similares